19-12527524-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144976.4(ZNF564):āc.584G>Cā(p.Gly195Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,613,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_144976.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZNF564 | NM_144976.4 | c.584G>C | p.Gly195Ala | missense_variant | 4/4 | ENST00000339282.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZNF564 | ENST00000339282.12 | c.584G>C | p.Gly195Ala | missense_variant | 4/4 | 1 | NM_144976.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 152000Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250910Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135846
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461852Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 727228
GnomAD4 genome AF: 0.0000461 AC: 7AN: 152000Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74226
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | The c.584G>C (p.G195A) alteration is located in exon 4 (coding exon 4) of the ZNF564 gene. This alteration results from a G to C substitution at nucleotide position 584, causing the glycine (G) at amino acid position 195 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at